As the Chief Research & Development Officer at Axogen, Angelo G. Scopelianos plays a pivotal role in advancing the company's mission to provide innovative solutions for peripheral nerve repair. Since his promotion in January 2021, Angelo has been at the forefront of discovery and new...
As the Chief Research & Development Officer at Axogen, Angelo G. Scopelianos plays a pivotal role in advancing the company's mission to provide innovative solutions for peripheral nerve repair. Since his promotion in January 2021, Angelo has been at the forefront of discovery and new product development, leveraging his extensive expertise in biomaterials, biologics, and drug-device combinations. His leadership is characterized by a commitment to translating groundbreaking research into life-enhancing products that meet the evolving needs of patients and healthcare providers.
Angelo's strategic vision is complemented by his ability to build and lead world-class, multi-disciplinary teams. He fosters a collaborative environment that encourages innovation and creativity, ensuring that Axogen remains a leader in the medical device industry. His focus on pioneering technology platforms has resulted in a sustainable pipeline of products that not only enhance surgical outcomes but also improve the quality of life for patients suffering from nerve injuries.
Key projects under Angelo's guidance include the development of advanced surgical instruments and the integration of stem cell technologies into existing product lines. His expertise in design control and quality assurance ensures that all products meet rigorous regulatory standards while maintaining the highest levels of efficacy and safety. As a visionary strategist, Angelo is dedicated to driving Axogen's research initiatives forward, positioning the company as a trailblazer in the field of regenerative medicine and peripheral nerve repair. Through his leadership, Axogen is not just creating products; it is transforming lives.
